Working Group 4

WEBINAR 2 – October 10th, 2024

“Lung cancer screening in G7 Cancer countries: challenges and lessons learned”

Working group 4 focuses on cancer prevention (prevention and early detection/diagnosis) and is organizing a webinar for all G7 Cancer organizations to share advances and challenges regarding their lung cancer screening strategies. The co-leads of this working group are: Claudia Mayer (DKFZ), Jessica Faupel-Badger (National Cancer Institute) and Anbu Paramasivam (CRUK).

October 10th, 2024

5am Los Angeles / Vancouver
8am Toronto
1pm London
2pm Paris

8am New York
9pm Tokyo
10pm Sydney

Lung cancer screening implementation across the G7 Cancer countries

Lessons learned from past initiatives, including successes, failures, and metrics of success

Perspectives on the future of lung cancer screening in each G7 country over the next five years

Introduction on the G7 Cancer

Co-leads of G7 Cancer’s working group 4 on Cancer Prevention:

Claudia Mayer (German Cancer Research Center – DKFZ)

Anbalakan Paramasivam (Cancer Research UK – CRUK)

Jessica Faupel-Badger (National Cancer Institute – NCI)

Introduction of the presentations by the moderators:

Rayjean J. Hung (Sinai Health and University of Toronto)
Canada Research Chair on Integrative Molecular EpidemiologyHead, Prosserman Centre for Population Health ResearchAssociate Director of Population Health, Lunenfeld-Tanenbaum Research Institute, Sinai Health Professor, Dalla Lana School of Public Health, University of Toronto

Hilary Robbins (International Agency for Research on Cancer)
Joint Lead, Risk Assessment and Early Detection Team Scientist, Genomic Epidemiology Branch

Presentations

United Kingdom’s perspective

Phil Crosbie ( University of Manchester / Wythenshawe Hospital,Manchester University NHS Foundation Trust)
Professor of Respiratory Medicine at the University of Manchester and Honorary Consultant in Respiratory Medicine at Wythenshawe Hospital, Manchester University NHS Foundation Trust. Member of the national expert advisory group for lung cancer screening in the UK, Early Detection lead for the Cancer Research UK Lung Cancer Centre of Excellence, research lead for the Manchester Lung Health Check programme and co-chief investigator of the Yorkshire Lung Screening Trial.

Australia’s perspective

Henry Marshall (Prince Charles Hospital, University of Queensland Thoracic Research Centre)
Thoracic Physician at The Prince Charles Hospital and University of Queensland Thoracic Research Centre

United States’ perspective

Ella A. Kazerooni (University of Michigan)
Professor of Radiology & Internal Medicine, Chair American Cancer Society National Lung Cancer Roundtable, Founding Chair American College of Radiology Lung Cancer Screening Registry & LungRADS, and lead for CT accreditation Lung Cancer Screening Designation

Canada’s perspective

Stephan Lam (BC Center)
Professor of Medicine at the University of British Columbia, Medical Director of the BC Lung Screening Program, Distinguished Scientist and Leon Judah Blackmore Chair in Lung Cancer Research at the BC Cancer Research Institute and chair of the Canadian Partnership Against Cancer Pan-Canadian Lung Cancer Screening Network

Questions and answers

Presentations

France’s perspective

Sébastien Couraud (Hospices Civils de Lyon)
Head of the specialized acute pulmonology and thoracic oncology department

Germany’s perspective

Rudolf Kaaks (German Cancer Research Center)
Head of DKFZ Division of Cancer Epidemiology

Japan’s perspective

Tomio Nakayama (National Cancer Center)
Chief of Division of Screening Assessment and Management

Questions and answers

Conclusion